Hoth Therapeutics, Inc. Gains 85.71%
Tue, Jan 04, 2022 at 05:30 PM
Hoth Therapeutics, Inc. (HOTH:NASDAQ) rocketted at $1.3, a gain of 85.7%. The stock got featured on our News Catalysts scanner on Tue, Jan 04, 2022 at 09:19 AM in the 'MISCELLANEOUS' category. From Mon, Dec 20, 2021, the stock recorded 33.33% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Hoth Therapeutics, Inc. (HOTH:NASDAQ)
Hoth Therapeutics Inc is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
Top 10 Gainers:
- ATA Creativity Global (AACG:NASDAQ), 114.29%
- TOAC (TOAC:NASDAQ), 100%
- AFAC (AFAC:NASDAQ), 100%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 85.71%
- NexTier Oilfield Solutions Inc. (NEX:NYSE), 26.62%
- NLSP (NLSP:NASDAQ), 26.05%
- REE (REE:NASDAQ), 20.61%
- WBEV (WBEV:NYSEMKT), 19.97%
- Oragenics, Inc. (OGEN:NYSEMKT), 18.44%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 18.37%